首頁 > 市場調查報告書 > 醫療設備

生技設備

基因檢測板市場規模、佔有率和成長分析（按產品/服務、技術、設計和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898579

基因檢測板市場規模、佔有率和成長分析（按產品/服務、技術、設計和地區分類）—產業預測（2026-2033 年）

Gene Panel Market Size, Share, and Growth Analysis, By Product and Services (Test Kits and Testing Services), By Technique (Amplicon-based Approach and Hybridization-based Approach), By Design, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 214 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，基因檢測市場規模將達到 34.1 億美元，到 2025 年將達到 40.7 億美元，到 2033 年將達到 167 億美元，在預測期（2026-2033 年）內，複合年成長率將達到 19.3%。

受個人化醫療和基因技術進步的推動，基因組檢測市場預計將迎來顯著成長。隨著基因測序成本的降低，針對多種疾病的全面基因檢測變得更加普及，從而滿足了遺傳性疾病日益成長的趨勢以及對個人化治療方案的需求。基因組檢測能夠提供關於遺傳易感性的寶貴資訊，在研究、診斷和治療方案開發中發揮著至關重要的作用。同時分析多個基因的效率提升，加深了我們對遺傳性疾病的理解，並有助於制定個人化的治療方案。隨著生物資訊學和定序技術的不斷進步，基因組檢測有望變得更加精準，並更深入地融入標準臨床工作流程，從而促進其在治療和預防領域的廣泛應用。

基因檢測市場促進因素

基因panel市場主要受次世代定序（NGS）技術進步的推動。 NGS技術能夠提高基因分析的準確性、加快處理速度並降低成本。這些創新使得全面的基因組分析成為可能，促進了個人化醫療的發展趨勢，並推動了臨床和科學研究領域對基因panel的需求。隨著NGS技術的不斷發展，人們對遺傳訊息的理解也日益深入，最終將帶來更完善的診斷和治療策略。這將進一步擴展基因panel在醫療保健和科學研究各領域的應用。

基因檢測市場的限制

由於醫療專業人員和患者對基因檢測缺乏了解和認知，基因檢測市場的發展可能面臨挑戰。對DNA檢測的益處和應用缺乏足夠的教育可能會減緩其普及速度，最終影響基因檢測市場的成長及其潛在效益。這種認知不足可能會降低醫療服務提供者和患者接受基因檢測的意願，從而影響整體市場潛力，並限制個人化醫療和個人化治療策略的發展。彌合這些教育差距對於促進市場成長和普及至關重要。

基因檢測市場趨勢

基因檢測市場正經歷顯著成長，這主要得益於個人化醫療的日益普及。這項轉變主要歸功於基因組技術的重大進步，醫療服務提供者逐漸認知到基於個別基因組圖譜進行治療的益處，從而實現更精準的診斷和標靶治療。隨著臨床醫生擴大利用基因檢測來最佳化患者照護並改善健康結果，對這些創新工具的需求也日益成長。這一趨勢反映了人們為提高治療效果和減少副作用所做的廣泛努力，也使基因檢測成為現代醫學發展中不可或缺的一部分。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Qiagen
Roche
Illumina
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
Becton, Dickinson and Company（BD）
Sangamo Therapeutics

簡介目錄

Product Code: SQMIG35H2314

Gene Panel Market size was valued at USD 3.41 Billion in 2024 and is poised to grow from USD 4.07 Billion in 2025 to USD 16.7 Billion by 2033, growing at a CAGR of 19.3% during the forecast period (2026-2033).

The market for gene panels is poised for significant growth, driven by advancements in personalized medicine and genetic technologies. As genomic sequencing costs decrease, comprehensive genetic testing for various disorders becomes more accessible, catering to the rising prevalence of hereditary diseases and the demand for tailored treatment solutions. Gene panels provide valuable insights into genetic predispositions, making them essential in research, diagnostics, and therapeutic development. Their efficiency in simultaneously analyzing multiple genes enhances understanding of hereditary conditions and aids in developing customized care plans. With ongoing improvements in bioinformatics and sequencing technologies, gene panels are expected to gain greater precision and integration into standard clinical workflows, fostering their increased use in therapeutic and preventive applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Gene Panel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Gene Panel Market Segments Analysis

Global Gene Panel Market is segmented by Product and Services, Technique, Design, Application, End User and Region. Based on Product and Services, the market is segmented into Test Kits, and Testing Services. Based on Technique, the market is segmented into Amplicon-based Approach, and Hybridization-based Approach. Based on Design the market is segmented into Predesigned Gene Panel, and Customized Gene Panel. Based on Application, the market is segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, and Pharmacogenetics. Based on end user, the market is segmented into Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Gene Panel Market

The gene panel market is significantly propelled by advancements in next-generation sequencing (NGS) technologies, which provide enhanced accuracy, faster processing times, and reduced costs for genetic analysis. These innovations facilitate comprehensive genomic profiling, fostering the trend toward personalized medicine and driving the demand for gene panels in both clinical and research settings. As the capabilities of NGS continue to evolve, they enable a deeper understanding of genetic information, ultimately enhancing diagnostic and therapeutic strategies, and further expanding the applicability of gene panels in various areas of healthcare and scientific research.

Restraints in the Gene Panel Market

The growth of the gene panel market may face challenges due to the limited understanding and knowledge of gene panel testing among healthcare professionals and patients. Insufficient education regarding the benefits and applications of DNA panels can result in a slower adoption rate, ultimately influencing the expansion of the genetic testing market and its potential benefits. This lack of awareness can hinder the willingness of both providers and patients to embrace gene panel testing, thereby impacting overall market potential and limiting advancements in personalized medicine and tailored treatment strategies. Addressing these educational gaps is essential for fostering market growth and acceptance.

Market Trends of the Gene Panel Market

The gene panel market is witnessing a significant surge driven by the increasing adoption of personalized medicine, as healthcare providers recognize the benefits of tailoring treatments based on individual genomic profiles. This shift is largely attributed to remarkable advancements in genomic technologies, which facilitate more precise diagnostics and targeted therapies. As clinicians increasingly leverage gene panels to optimize patient care and enhance health outcomes, there is a growing demand for these innovative tools. This trend reflects a broader commitment to enhancing treatment efficacy and minimizing adverse effects, positioning gene panels as essential components in the evolution of modern healthcare.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Pricing Analysis

Global Gene Panel Market Size by Product and Service & CAGR (2026-2033)

Test Kits
Testing Services

Global Gene Panel Market Size by Technique & CAGR (2026-2033)

Amplicon-based Approach
Hybridization-based Approach

Global Gene Panel Market Size byDesign & CAGR (2026-2033)

Predesigned Gene Panel
Customized Gene Panel

Global Gene Panel Market Size byApplication & CAGR (2026-2033)

Cancer Risk Assessment
- Syndrome-specific
- High-penetrance
- High and Moderate-penetrance
- Comprehensive Cancer Risk
Diagnosis of Congenital Diseases
Pharmacogenetics
Other Applications

Global Gene Panel Market Size by End-use & CAGR (2026-2033)

Research and Academic Institutes
Hospital and Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies

Global Gene Panel Market Size & CAGR (2026-2033)

North America, (Product and Services, Technique, Design, Application, End User)
- US
- Canada
Europe, (Product and Services, Technique, Design, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product and Services, Technique, Design, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product and Services, Technique, Design, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product and Services, Technique, Design, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sangamo Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates